The DOI matches its Crossref record.
Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal
Abstract
Transcatheter arterial chemoembolization (TACE) improves the treatment of hepatocellular carcinoma (HCC) by causing tumour necrosis and shrinkage. Fifty-two patients with resectable large HCC (defined as a maximal tumour diameter of 10 cm or more) were prospectively randomized into two groups: group 1 comprised 24 patients who had 1–5 sessions of TACE before operation; group 2 consisted of the other 28 patients, on whom surgery was performed without delay. Tumour volume was reduced to a mean(s.d.) of 42·8(15·3) per cent in 16 patients in group 1, but remained unchanged in four and increased in size in a further four. Patients in group 1 had a slightly longer operating time (5·5 versus 4·6 h, P = 0·09), a higher rate of concomitant resection of adjacent organs (58 versus 25 percent, P = 0·03) and a higher rate of histological invasion to these organs (33 versus 4 per cent, P = 0·01). No difference was found between the two groups in operative blood loss, operative morbidity and mortality rates, and pathological staging. The disease-free survival rate in the two groups was similar, but the incidence of extrahepatic cancer recurrence was higher in group 1 (57 versus 23 per cent, P = 0·03). The actuarial survival rate was also significantly worse in group 1 when determined from the time of detection of the tumour (P = 0·03) or from operation (P = 0·01). It is concluded that preoperative TACE for resectable large HCC should be avoided because it does not provide complete necrosis in large tumours and results in delayed surgery and difficulty in the treatment of recurrent lesions, without any benefit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Resection and Liver Transplantation for Hepatocellular Carcinoma
Llovet, J. M., Schwartz, M., & Mazzaferro, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-871198 · Cited by 879
Cammà, C., Schepis, F., Orlando, A., Albanese, M., Shahied, L., Trevisani, F., Andreone, P., Craxì, A., & Cottone, M. (2002) · Radiology · doi:10.1148/radiol.2241011262 · Cited by 851
Novel advancements in the management of hepatocellular carcinoma in 2008
Llovet, J. M., & Bruix, J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.022 · Cited by 815
Tung-Ping Poon, R., Fan, S.-T., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00003 · Cited by 811
Quality of Complication Reporting in the Surgical Literature
Martin, R. C. G., Brennan, M. F., & Jaques, D. P. (2002) · Annals of Surgery · doi:10.1097/00000658-200206000-00007 · Cited by 621
Metadata
- Authors
- Wu, C.-C., Ho, Y.-Z., Ho, W. L., Wu, T.-C., Liu, T.-J., & P'Eng, F.-K.
- Venue
- Journal of British Surgery
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-01-01
- Volume
- 82
- Issue
- 1
- Pages
- 122-126
- ISSN
- 0007-1323 (ISSN-L)
- 1365-2168
- OpenAlex
- W2080321731
- Cited by
- 218
- References
- 0
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. https://app.cochat.ai/papers/10.1002/bjs.1800820141
- The paper
- Wu, C.-C., Ho, Y.-Z., Ho, W. L., Wu, T.-C., Liu, T.-J., & P'Eng, F.-K. (1995). Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal. Journal of British Surgery. https://doi.org/10.1002/bjs.1800820141
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.